The effect of grape seed extract in ulcerative colitis
Phase 3
Recruiting
- Conditions
- Patients with ulcerative colitis.Ulcerative colitis
- Registration Number
- IRCT20120415009472N28
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
BMI of patients between 18.5-35 kg/m2
Diagnosis of ulcerative colitis in the mild to moderate stage by a gastroenterologist based on patient tests, patient symptoms (disease severity questionnaire)and colonoscopy.
Patients using only one of the drug groups (5-aminosalicylic acid (Petasa, Mesalazine or Asacol), as well as Azathioprine.
Exclusion Criteria
Pregnancy and breastfeeding
Taking anticoagulants such as warfarin or heparin
Suffering from other intestinal diseases, autoimmune diseases, cancer, inflammatory diseases, and infectious diseases.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method